| Particulars |
|
|
|
|
Company Name
| Zydus Lifesciences Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
99.75 |
B.V. (₹) |
237.30 |
| Sales(₹ Cr.) |
11,486.40 |
NP (₹ Cr.) |
3,691.18 |
| NP Var% |
-36.00 |
Div% |
100.00 |
| CPS(₹) |
42.60 |
EPS (₹) |
37.00 |
| Traded Value(₹ Lakhs) |
2,167.87 |
52 Week High |
1,264.00 |
| 52 Week Low |
836.00 |
Price BSE |
1,239.00 |
| Price NSE |
1,241.00 |
Market Capital (₹ Cr.) |
123,590.72 |
| P/C Ratio |
29.10 |
P/E Ratio |
33.50 |
| Price Vs.BV |
5.22 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
2,723.50 |
| NP(₹ Cr.) |
339.60 |
NP Var % |
-12.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
11,945.40 |
| OPM |
48.07 |
NP |
4,352.72 |
| NP Var% |
-18.25 |
EPS |
36.54 |
| PE |
33.91 |
|
|